Clearance of Hepatitis C Virus following Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma: Case Report

Clearance of Hepatitis C Virus following Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma: Case Report

Introduction: Patients with advanced hepatocellular carcinoma (HCC) have limited treatment options in the context of decompensated cirrhosis. HCC occurs in patients with hepatitis C virus (HCV) infection and cirrhosis at 1–4% per year. Direct-acting antiviral (DAA) efficacy is decreased in the prese...

書目詳細資料
Main Authors:	Harry Wilson, Douglas Macdonald, Kathleen Bryce
格式:	Article
語言:	English
出版:	Karger Publishers 2024-06-01
叢編:	Case Reports in Gastroenterology
主題:	hepatitis c immunotherapy hepatocellular carcinoma
在線閱讀:	https://beta.karger.com/Article/FullText/539646

相似書籍

Hepatic arterial infusion chemotherapy combined with immune checkpoint inhibitors and molecular targeted therapies for advanced infiltrative hepatocellular carcinoma: a single-center experience
由: Zizhuo Wang, et al.
出版: (2025-01-01)

Immune Checkpoint Inhibitors in HBV-Caused Hepatocellular Carcinoma Therapy
由: Jin Zhang, et al.
出版: (2023-03-01)

Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
由: Samantha M. Ruff, et al.
出版: (2023-06-01)

First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials
由: Giuseppe Cabibbo, et al.
出版: (2021-11-01)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: An Overview
由: Diederick J. van Doorn, et al.
出版: (2020-12-01)

Research Progress on Immune Checkpoint Inhibitors in Treatment of Hepatocellular Carcinoma
由: CAO Jiali, et al.
出版: (2023-05-01)

Immunotherapy with Checkpoint Inhibitors for Hepatocellular Carcinoma: Where Are We Now?
由: Francesco Tovoli, et al.
出版: (2020-10-01)

Advances in immune checkpoint inhibitors for hepatocellular carcinoma
由: Ji Won Han, et al.
出版: (2021-09-01)

The load of hepatitis B virus reduces the immune checkpoint inhibitors efficiency in hepatocellular carcinoma patients
由: Zhengzheng Ji, et al.
出版: (2024-11-01)

The Extended Surgical Concepts for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors
由: Hsu HM, et al.
出版: (2023-10-01)

Progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma
由: Tong Liu, et al.
出版: (2024-08-01)

Lessons From Immune Checkpoint Inhibitor Trials in Hepatocellular Carcinoma
由: Raphael Mohr, et al.
出版: (2021-03-01)

Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma
由: Ziyu Liu, et al.
出版: (2019-11-01)

Hepatitis B virus reactivation in hepatocellular carcinoma patients after hepatic arterial infusion chemotherapy combined with and without immunotherapy
由: Lijie Zhang, et al.
出版: (2024-04-01)

Biomarkers predicting the efficacy of immune checkpoint inhibitors in hepatocellular carcinoma
由: Ran Qin, et al.
出版: (2023-12-01)

Hepatic angiomyolipoma with minimal fat, mimicking hepatocellular carcinoma
由: So Jung Lee, et al.
出版: (2012-09-01)

Meta-analysis of the efficiency and safety of neoadjuvant therapy with immune checkpoint inhibitors in resectable hepatocellular carcinoma
由: Adili Tuersun, et al.
出版: (2025-01-01)

Hepatocellular carcinoma in hepatitis D: Does it differ from hepatitis B monoinfection?
由: Zaigham Abbas, et al.
出版: (2012-01-01)

Editorial: Biomarkers of Immune-Checkpoint-Inhibitor Immunotherapies in Hepatocellular Carcinomas
由: Zhanjun Guo, et al.
出版: (2022-03-01)

Natural Killer Cells and T Cells in Hepatocellular Carcinoma and Viral Hepatitis: Current Status and Perspectives for Future Immunotherapeutic Approaches
由: Suresh Gopi Kalathil, et al.
出版: (2021-05-01)

Neoadjuvant Immune Checkpoint Inhibitors in hepatocellular carcinoma: a meta-analysis and systematic review
由: Chunhong Tian, et al.
出版: (2024-02-01)

Safety in treatment of hepatocellular carcinoma with immune checkpoint inhibitors as compared to melanoma and non-small cell lung cancer
由: Zachary J. Brown, et al.
出版: (2017-11-01)

Prospect of the use of checkpoint inhibitors in hepatocellular cancer treatments
由: Raufi A, et al.
出版: (2017-02-01)

A single hepatic mass with two tales: hepatic tuberculosis and hepatocellular carcinoma
由: Yi De Ian Koh, et al.
出版: (2023-09-01)

Hepatitis C virus-induced hepatocellular carcinoma
由: Nicolas Goossens, et al.
出版: (2015-06-01)

Heterogeneity in polyamine metabolism dictates prognosis and immune checkpoint blockade response in hepatocellular carcinoma
由: Jianyan Pan, et al.
出版: (2025-02-01)

Safety and Efficacy of Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma
由: Fei Yang, et al.
出版: (2022-01-01)

Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors
由: Y. Linda Wu, et al.
出版: (2023-02-01)

The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection
由: Jung Hwan Yu, et al.
出版: (2022-07-01)

Hepatic resection for recurrent hepatocellular carcinoma during pregnancy: a case report
由: Takashi Maeda, et al.
出版: (2020-09-01)

Advances in radiotherapy and immunity in hepatocellular carcinoma
由: Yuhan Yang, et al.
出版: (2023-08-01)

Antiviral therapy and risk for hepatocellular carcinoma in chronic viral hepatitis
由: D T Abdurakhmanov
出版: (2013-10-01)

Hepatic arterial changes following iodized oil chemoembolization of hepatocellular carcinoma: Incidence and technical consequence
由: Ron C. Gaba, et al.
出版: (2011-09-01)

Hepatitis B Virus-Associated Hepatocellular Carcinoma
由: Giacomo Emanuele Maria Rizzo, et al.
出版: (2022-05-01)

Clinical practice guidelines and real-life practice on hepatocellular carcinoma: the Hong Kong perspective
由: Rex Wan-Hin Hui, et al.
出版: (2023-04-01)

Hepatocellular Carcinoma Patients with Hepatitis B Virus Infection Exhibited Favorable Survival from Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
由: Qi Du, et al.
出版: (2023-10-01)

Association of hepatitis status with surgical outcomes in patients with dual hepatitis B and C related hepatocellular carcinoma
由: Xiu-Tao Fu, et al.
出版: (2017-05-01)

The Global Impact of Hepatitis B Vaccination on Hepatocellular Carcinoma
由: Joan Ericka Flores, et al.
出版: (2022-05-01)

Genomic instabilities in hepatocellular carcinoma: biomarkers and application in immunotherapies
由: Jui-Hsiang Hung, et al.
出版: (2024-11-01)

The safety and efficacy of TACE combined with HAIC, PD-1 inhibitors, and tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: a retrospective study
由: Zhongjing Huang, et al.
出版: (2024-01-01)